1303GCC: Trastuzmab & Pertuzumab Alone or in Combination With Hormonal Therapy or Chemotherapy With Eribulin in Women Aged 60 and Over With HER2/Neu Overexpressed Locally Advanced or MBC
Condition: Metastatic Breast CancerInterventions: Drug: Trastuzumab plus Pertuzumab; Drug: Hormonal Therapy with Anastrozole and Fulvestrant; Drug: Chemotherapy with EribulinSponsors: Katherine Tkaczuk; Genentech, Inc.Recruiting - verified January 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Arimidex | Cancer & Oncology | Chemotherapy | HER2 | Hormonal Therapy | Hormones | Research | Women